-
TIME
ACTIVITIES
-
8:00 – 9:00
Registration
-
9:00 – 9:15
Opening Remarks
Speaker: David Chen, Managing Director, BFC Group
-
Session 1:
Asymchem Global Pharma &Biotech Symposium
-
9:15 – 10:15
Cross-border licensing deal trend – Perspective from leading biopharma players
Moderator:Christina Zhang, Partner-in-Charge of Shanghai Office, Cooley LLP
Panelists:
Glenn P. Sblendorio, M.B.A., President and Chief Executive Officer, Ophthotech Corporation
Lila Hope, Partner in Global Life Sciences Partnering and Licensing Group, Cooley LLP
Samuel Murphy, VP and Head of International Business Development, Salubris Pharmaceuticals
Gayatri Varma, Director, Partnering & Strategy at MedImmune The Early Stage Biologics R&D Unit, AstraZeneca
Astrid Maria Dahl, Ph.D., MBA, Executive Business Development Director - Oncology, AstraZeneca
-
10:15 – 11:15
IPO market in US and Hong Kong – Getting the best of both markets
Moderator:Charlie Kim, Partner and Co-Head of Global Capital Markets Group at Cooley
Panelists:
David Ke, Executive Director, J.P. Morgan Investment Bank, Healthcare Equity Capital Markets
Lili Zheng, Managing Partner, Deloitte
David Lau, Managing Director and Head of Investment Banking, J.P. Morgan Hong Kong
Y. Katherine Xu, Partner and Co-Head of the Biopharmaceutical Equity Research Group, William Blair
Jonie Kondracki, Partner in Global Capital Markets Group, Cooley LLP
-
11:15 – 11:45
Tea Break
-
11:45 – 12:45
Access to China: Market, Regulation, Science, Investment and Solutions
Moderator:Dr. James Gage, Chief Scientific Officer of Asymchem
Panelists:
Dr. Ruyi He, Former Chief Scientist, China Food and Drug Administration (CFDA)
Kevin(Penghui) Chen, Founding Partner, Biotrack Capital
Michael Kaufman, SVP, Mersana Therapeutics
Jessica Li, Head of Asia Pacific Healthcare Investment Banking, Bank of America Merrill Lynch (BAML)
Karen Liu, Founding Partner, 3E Bioventures Capital
-
12:45 – 14:00
AsymChem Lunch Reception
-
Session 2:
Session 2: BFC Global Healthcare BD & Investment Forum
-
14:00 – 15:00
State of Healthcare Investment in China and US
Moderator:Yumin (Benjamin) Qiu, Partner, Advantech
Panelists:
Michael Xue, Managing Director, Morningside Ventures
Armen B Shanafelt, General Partner, Lilly Ventures
Xiaobo Lu, Partner, Sequoia Capital China
Yining Zhao, Co-Founder & Executive Chairman, Transcenta Holding
-
15:00 – 15:30
Tea Break
-
15:30 – 17:00
